March 2, 2026: Gastrointestinal Lawsuits Involving Trulicity, Other GLP-1s Increase in March Eli Lilly and one other drug company are facing 3,363 lawsuits in a consolidated MDL, in which plaintiffs accuse the companies of failing to warn patients about the gastrointestinal risks of taking Trulicity and other GLP-1s
More research, including longer-term studies with a greater number of participants, is needed to ensure that all of the potential risks associated with semaglutide are discovered
This makes it particularly relevant during caloric restriction, when the body is more prone to catabolizing muscle tissue for energy
You will learn how L-glutathione functions as the active molecule and how liposomal delivery acts as a protective vehicle to ensure that molecule reaches your cells
Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: novel mechanistic insight
But, with so much information available, it can be challenging to determine which acid is the right fit for your unique skin type and concerns
